Inbio Ventures is a management company for Pharmstandard International (Luxembourg), a private venture capital fund, fully committed by the #1 pharmaceutical company in Russia, PJSC Pharmstandard (LSE: PHST).
We are the ambitious team of professionals with comprehensive experience in academic and biopharmaceutical industry, drug discovery and development, venture investments. We are supported by the Advisory Board of internationally recognized KOLs in various therapeutic areas. We are dedicated to investing in breakthrough drug development projects worldwide.
Due to our strategic alignments with the Generium/Pharmstandard group of companies we can offer to our partners much more than purely financial investors do – we position ourselves not only as a VC investor, but also as a strategic/co-development partner all the way from early-stage R&D to market access.